1. Home
  2. CLDX vs LAUR Comparison

CLDX vs LAUR Comparison

Compare CLDX & LAUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • LAUR
  • Stock Information
  • Founded
  • CLDX 1983
  • LAUR 1989
  • Country
  • CLDX United States
  • LAUR United States
  • Employees
  • CLDX N/A
  • LAUR N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LAUR Other Consumer Services
  • Sector
  • CLDX Health Care
  • LAUR Real Estate
  • Exchange
  • CLDX Nasdaq
  • LAUR Nasdaq
  • Market Cap
  • CLDX 2.9B
  • LAUR 2.8B
  • IPO Year
  • CLDX 2008
  • LAUR 2017
  • Fundamental
  • Price
  • CLDX $23.55
  • LAUR $18.51
  • Analyst Decision
  • CLDX Buy
  • LAUR Buy
  • Analyst Count
  • CLDX 8
  • LAUR 2
  • Target Price
  • CLDX $64.83
  • LAUR $18.50
  • AVG Volume (30 Days)
  • CLDX 1.1M
  • LAUR 720.6K
  • Earning Date
  • CLDX 11-06-2024
  • LAUR 10-31-2024
  • Dividend Yield
  • CLDX N/A
  • LAUR 3.78%
  • EPS Growth
  • CLDX N/A
  • LAUR 137.96
  • EPS
  • CLDX N/A
  • LAUR 1.57
  • Revenue
  • CLDX $9,976,000.00
  • LAUR $1,552,681,000.00
  • Revenue This Year
  • CLDX N/A
  • LAUR $6.85
  • Revenue Next Year
  • CLDX N/A
  • LAUR $3.53
  • P/E Ratio
  • CLDX N/A
  • LAUR $11.52
  • Revenue Growth
  • CLDX 128.55
  • LAUR 9.25
  • 52 Week Low
  • CLDX $23.49
  • LAUR $12.45
  • 52 Week High
  • CLDX $53.18
  • LAUR $19.12
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 29.53
  • LAUR 70.55
  • Support Level
  • CLDX $25.56
  • LAUR $18.19
  • Resistance Level
  • CLDX $28.15
  • LAUR $18.95
  • Average True Range (ATR)
  • CLDX 1.62
  • LAUR 0.57
  • MACD
  • CLDX 0.14
  • LAUR 0.14
  • Stochastic Oscillator
  • CLDX 1.27
  • LAUR 84.52

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About LAUR Laureate Education Inc.

Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.

Share on Social Networks: